Diego A Díaz-García: Bridging Clinical Understanding and Biology in Cancer Cachexia
Diego A Díaz-García, Medical Oncologist, CEO, and Founder of CánCare – Advanced Oncology Specialty, shared a post on X about a paper by Kexin Koh et al. published in the Cancer Discovery:
“Cancer-Associated Cachexia is a chronic wasting syndrome linked to advanced cancer, marked by loss of function, poor therapy tolerance, and no globally approved treatments.
Human studies now map clinical features, identify mediators, and outline strategies to improve survival and quality of life.”
Title: Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies
Authors: Kexin Koh, Rachel Scott, Elizabeth M. Cespedes Feliciano, Tobias Janowitz, Marcus D. Goncalves, Eileen P. White, Barry J.A. Laird, Kerstin Haase, Mariam Jamal-Hanjani
More posts featuring Diego A. Díaz-García on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023